Market Overview

UPDATE: Jefferies Downgrades Ventas to Hold on Valuation and Post-Acute Concerns

Share:
Related VTR
Jim Cramer Shares His Thoughts On Cabelas, Ventas And Ford Motor
Earnings Scheduled For April 29, 2016
April Showers Bring May Dividends (Seeking Alpha)

Jefferies reduced its rating on Ventas (NYSE: VTR) from Buy to Hold but raised its price target from $65 to $66.

Jefferies noted, "Downgrading VTR to Hold on post-acute care concerns and valuation: Healthcare REITs with meaningful exposure to LTACs and IRFs include Medical Property Trust (MPW, Hold, $11.61) and Ventas (VTR, Hold, $64.51). At MPW, it is 43% of the asset base, and at VTR, we estimate it is 5% to 8% of net operating income (NOI). We are downgrading VTR to a Hold rating from our prior Buy rating given this concern. As valuation appears full at 16.4x P/FFO and a 5.3% implied cap rate, we believe the risk/reward with VTR stock is now balanced, rather than being favorable."

Ventas closed at $64.51 on Monday.

Latest Ratings for VTR

DateFirmActionFromTo
Apr 2016CitigroupMaintainsNeutral
Mar 2016Goldman SachsDowngradesBuyNeutral
Mar 2016Mizuho SecuritiesUpgradesNeutralBuy

View More Analyst Ratings for VTR
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (VTR)

View Comments and Join the Discussion!